Buscar resultados de ensayos clínicos

Patrocinado por

Long QT Syndrome - 33 Studies Found

Estado Estudiar
Completed Nombre del estudio: Long QT Syndrome-Population Genetics and Cardiac Studies
Condición:
  • Cardiovascular Diseases
  • Heart Diseases
  • Ventricular Arrhyth
    Fecha: 2000-05-25
Completed Nombre del estudio: Hydroxyzine and Risk of Prolongation of QT Interval
Condición:
  • Hydroxyzine
  • Long QT Syndrome

Fecha: 2016-06-17
Completed Nombre del estudio: Effect of Beta-blocker Therapy on QTc Response in Exercise and Recovery in Normal Subjects
Condición:
  • Long QT Syndrome
  • Cardiac Repolarization

Fecha: 2007-12-26
Intervenciones:
  • Drug: Placebo Placebo will be

Completed Nombre del estudio: Study Evaluating the Effects of Multiple Oral Doses of ERB-041 on Cardiac Repolarization in Healthy Subjects
Condición:
  • Healthy
  • Long QT Syndrome

Fecha: 2006-04-18
Intervenciones: Drug: ERB-041
Recruiting Nombre del estudio: Worm Study: Modifier Genes in Sudden Cardiac Death
Condición:
Fecha: 2025-09-05
ACTIVE_NOT_RECRUITING Nombre del estudio: Study of LQT-1213 on Dofetilide-Induced QTc Prolongation in Healthy Adult Subjects and Patients Diagnosed With Type 2 or 3 Long QT Syndrome
Condición:
Fecha: 2025-09-05
Intervenciones: LQT-1213 is a serum glucocorticoid regulated kinase 1 (SGK-1) inhibitor
NOT_YET_RECRUITING Nombre del estudio: A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
Condición:
Fecha: 2025-09-05
Intervenciones: This device is expected to be used for the static 12-lead ECG to detect whether there are abnormal ECG signals related to diseases and outputs the res
Completed Nombre del estudio: Comparing Direct vs Indirect Methods for Cascade Screening
Condición: Long QT Syndrome
Fecha: 2025-09-05
Intervenciones: Study team members will directly contact potentially impacted family members to offer genetic testing of relevant variant.
Completed Nombre del estudio: Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2).
Condición: Long QT Syndrome
Fecha: 2025-09-05
Intervenciones: LQT-1213 is a serum glucocorticoid regulated kinase 1 (SGK-1) inhibitor
Completed Nombre del estudio: Healthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations
Condición: Long QT Syndrome
Fecha: 2025-09-05
Intervenciones: MRI cardiac
<<< Previous | Next >>>